Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-07-16 Sale |
2025-07-18 6:00 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $52.95 | $529,467 | 222,693 (Direct) |
View |
| 2025-07-10 Sale |
2025-07-11 6:30 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
30,000 | $51.16 | $1,534,895 | 520,757 (Direct) |
View |
| 2025-07-07 Sale |
2025-07-09 7:00 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
12,500 | $51.09 | $638,661 | 187,057 (Direct) |
View |
| 2025-07-01 Sale |
2025-07-03 6:00 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
2,000 | $52.88 | $105,760 | 29,891 (Direct) |
View |
| 2025-06-18 Sale |
2025-06-20 9:09 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
6,620 | $54.84 | $363,041 | 549,867 (Direct) |
View |
| 2025-06-18 Sale |
2025-06-20 9:08 pm |
Akero Therapeutics Inc. | AKRO | Gangloff Scott A. Chief Technology Officer |
848 | $54.84 | $46,504 | 23,452 (Direct) |
View |
| 2025-06-20 Sale |
2025-06-20 9:08 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
875 | $54.59 | $47,766 | 31,698 (Direct) |
View |
| 2025-06-18 Sale |
2025-06-20 9:07 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,129 | $54.84 | $61,914 | 166,234 (Direct) |
View |
| 2025-06-18 Sale |
2025-06-20 9:07 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
1,634 | $54.84 | $89,609 | 57,521 (Direct) |
View |
| 2025-06-18 Sale |
2025-06-20 9:07 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
1,633 | $54.84 | $89,554 | 90,598 (Direct) |
View |
| 2025-06-18 Sale |
2025-06-20 9:06 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
1,453 | $54.84 | $79,683 | 256,594 (Indirect Direct) |
View |
| 2025-06-16 Sale |
2025-06-20 09:22 am |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $54.23 | $542,306 | 92,231 (Direct) |
View |
| 2025-06-16 Sale |
2025-06-20 09:22 am |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
2,000 | $54.14 | $108,272 | 96,755 (Direct) |
View |
| 2025-06-10 Sale |
2025-06-12 6:34 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
37,837 | $54.05 | $2,044,940 | 556,487 (Direct) |
View |
| 2025-06-10 Sale |
2025-06-12 6:33 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
2,358 | $54 | $127,323 | 167,363 (Direct) |
View |
| 2025-06-10 Sale |
2025-06-12 6:33 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
2,804 | $53.99 | $151,402 | 59,155 (Direct) |
View |
| 2025-06-10 Sale |
2025-06-12 6:33 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
2,803 | $54 | $151,351 | 92,231 (Direct) |
View |
| 2025-06-10 Sale |
2025-06-12 6:32 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
919 | $54 | $49,625 | 32,573 (Direct) |
View |
| 2025-06-10 Sale |
2025-06-12 6:32 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
2,493 | $53.99 | $134,605 | 258,047 (Indirect Direct) |
View |
| 2025-06-05 Sale |
2025-06-09 5:30 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
37,500 | $54.52 | $2,044,634 | 202,543 (Direct) |
View |
| 2025-06-02 Sale |
2025-06-04 5:36 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
4,000 | $50.31 | $201,258 | 99,674 (Direct) |
View |
| 2025-05-22 Sale |
2025-05-23 5:30 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
4,000 | $50 | $200,000 | 118,396 (Direct) |
View |
| 2025-05-15 Sale |
2025-05-19 7:06 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $39.3 | $392,978 | 105,034 (Direct) |
View |
| 2025-05-12 Sale |
2025-05-13 9:11 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
30,000 | $41.48 | $1,244,455 | 594,324 (Direct) |
View |
| 2025-05-07 Sale |
2025-05-09 7:18 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
8,000 | $42.49 | $339,950 | 103,674 (Direct) |
View |
| 2025-05-06 Sale |
2025-05-08 7:34 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
12,500 | $43.43 | $542,864 | 182,610 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-07-16 Exercise |
2025-07-18 6:00 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $0 | 222,693 (Direct) |
View |
| 2025-07-16 Exercise |
2025-07-18 6:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $19.87 | 222,693 (Direct) |
View |
| 2025-07-07 Exercise |
2025-07-09 7:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
12,500 | $21.09 | 187,057 (Direct) |
View |
| 2025-07-07 Exercise |
2025-07-09 7:00 pm |
N/A 2029-12-12 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
12,500 | $0 | 187,057 (Direct) |
View |
| 2025-06-30 Option Award |
2025-07-02 6:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
890 | $23.87 | 91,488 (Direct) |
View |
| 2025-06-30 Option Award |
2025-07-02 6:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
890 | $23.87 | 257,484 (Direct) |
View |
| 2025-06-30 Option Award |
2025-07-02 6:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
193 | $23.87 | 31,891 (Direct) |
View |
| 2025-06-30 Option Award |
2025-07-02 6:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
890 | $23.87 | 58,411 (Direct) |
View |
| 2025-06-30 Option Award |
2025-07-02 6:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
890 | $23.87 | 167,124 (Direct) |
View |
| 2025-06-30 Option Award |
2025-07-02 6:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Gangloff Scott A. Chief Technology Officer |
299 | $23.87 | 23,751 (Direct) |
View |
| 2025-06-30 Option Award |
2025-07-02 6:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
890 | $23.87 | 550,757 (Direct) |
View |
| 2025-06-16 Exercise |
2025-06-20 09:22 am |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $0 | 92,231 (Direct) |
View |
| 2025-06-16 Exercise |
2025-06-20 09:22 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $21.1 | 92,231 (Direct) |
View |
| 2025-06-16 Exercise |
2025-06-20 09:22 am |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
2,000 | $0 | 96,755 (Direct) |
View |
| 2025-06-16 Exercise |
2025-06-20 09:22 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
2,000 | $19.87 | 96,755 (Direct) |
View |
| 2025-06-06 Exercise |
2025-06-09 5:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
24,611 | $21.09 | 202,543 (Direct) |
View |
| 2025-06-05 Exercise |
2025-06-09 5:30 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
37,500 | $0 | 202,543 (Direct) |
View |
| 2025-06-05 Exercise |
2025-06-09 5:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
12,889 | $21.1 | 202,543 (Direct) |
View |
| 2025-06-03 Option Award |
2025-06-05 4:07 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
9,398 | $0 | 9,398 (Direct) |
View |
| 2025-06-03 Option Award |
2025-06-05 4:06 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
9,398 | $0 | 293,762 (Direct) |
View |
| 2025-06-03 Option Award |
2025-06-05 4:06 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director |
9,398 | $0 | 9,398 (Direct) |
View |
| 2025-06-03 Option Award |
2025-06-05 4:05 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Xu Yuan Director |
9,398 | $0 | 9,398 (Direct) |
View |
| 2025-06-03 Option Award |
2025-06-05 4:05 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
9,398 | $0 | 9,398 (Direct) |
View |
| 2025-06-03 Option Award |
2025-06-05 4:05 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Judy Chou Director |
9,398 | $0 | 9,398 (Direct) |
View |
| 2025-06-03 Option Award |
2025-06-05 4:05 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
9,398 | $0 | 1,211,566 (Direct) |
View |
| 2025-06-02 Exercise |
2025-06-04 5:36 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
4,000 | $0 | 99,674 (Direct) |
View |
| 2025-06-02 Exercise |
2025-06-04 5:36 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
4,000 | $19.87 | 99,674 (Direct) |
View |
| 2025-05-22 Exercise |
2025-05-23 5:30 pm |
N/A 2033-01-09 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
4,000 | $0 | 118,396 (Direct) |
View |
| 2025-05-22 Exercise |
2025-05-23 5:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
4,000 | $44.37 | 118,396 (Direct) |
View |
| 2025-05-15 Exercise |
2025-05-19 7:06 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $0 | 105,034 (Direct) |
View |
| 2025-05-15 Exercise |
2025-05-19 7:06 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $21.1 | 105,034 (Direct) |
View |
| 2025-05-07 Exercise |
2025-05-09 7:18 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
8,000 | $0 | 103,674 (Direct) |
View |
| 2025-05-07 Exercise |
2025-05-09 7:18 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
8,000 | $19.87 | 103,674 (Direct) |
View |
| 2025-05-06 Exercise |
2025-05-08 7:34 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
12,500 | $0 | 182,610 (Direct) |
View |
| 2025-05-06 Exercise |
2025-05-08 7:34 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
12,500 | $21.1 | 182,610 (Direct) |
View |